Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ben Ponvilawan

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2022
Mortality Risk After Atypical Femoral Fracture: A Systematic Review and Meta-analysisNipith Charoenngam, Thanitsara Rittiphairoj, Aunchalee Jaroenlapnopparat, et al.
Infection|January 5, 2022
Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysisNipith Charoenngam, Ben Ponvilawan, Jerapas Thongpiya, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2023
Bone Fragility in Hereditary Connective Tissue Disorders: A Systematic Review and Meta-AnalysisNipith Charoenngam, Thanitsara Rittiphairoj, Ben Ponvilawan, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Molecular Tumor Board-Directed Treatment for Patients with Advanced-Stage Solid Tumors: A Case-Control Real-World StudyBen Ponvilawan, Dhruv Bansal, Karnav Modi, et al.
Ecancermedicalscience|April 22, 2025
Effect on cardiovascular outcome of sodium-glucose co-transporter-2 (SGLT2) inhibitors among cancer patients treated with anthracycline: a systematic review and meta-analysisChalothorn Wannaphut, Phuuwadith Wattanachayakul, Sakditad Saowapa, et al.
Heliyon|January 15, 2025
Clinical outcomes and adverse events of Hedgehog pathway inhibitors for advanced basal cell carcinoma patients: A systematic review and meta-analysisSuvijak Untaaveesup, Wichapol Dendumrongsup, Pornteera Srichana, et al.
Frontiers in Oncology|June 6, 2022
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in CholangiocarcinomaOrawan Suppramote, Sunisa Prasopporn, Satinee Aroonpruksakul, et al.
Journal of Gastroenterology and Hepatology|May 21, 2024
Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019Pojsakorn Danpanichkul, Thanida Auttapracha, Siwanart Kongarin, et al.
Frontiers in Oncology|January 23, 2023
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinomaSunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, et al.
JCO Precision Oncology|May 6, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung CancerDhruv Bansal, Ben Ponvilawan, Dmitrii Grachev, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|August 14, 2022
Mortality Risk After Atypical Femoral Fracture: A Systematic Review and Meta-analysisNipith Charoenngam, Thanitsara Rittiphairoj, Aunchalee Jaroenlapnopparat, et al.
Infection|January 5, 2022
Body mass index and risk of clostridioides difficile infection: a systematic review and meta-analysisNipith Charoenngam, Ben Ponvilawan, Jerapas Thongpiya, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2023
Bone Fragility in Hereditary Connective Tissue Disorders: A Systematic Review and Meta-AnalysisNipith Charoenngam, Thanitsara Rittiphairoj, Ben Ponvilawan, et al.
Current Oncology (Toronto, Ont.)|June 25, 2026
Molecular Tumor Board-Directed Treatment for Patients with Advanced-Stage Solid Tumors: A Case-Control Real-World StudyBen Ponvilawan, Dhruv Bansal, Karnav Modi, et al.
Ecancermedicalscience|April 22, 2025
Effect on cardiovascular outcome of sodium-glucose co-transporter-2 (SGLT2) inhibitors among cancer patients treated with anthracycline: a systematic review and meta-analysisChalothorn Wannaphut, Phuuwadith Wattanachayakul, Sakditad Saowapa, et al.
Heliyon|January 15, 2025
Clinical outcomes and adverse events of Hedgehog pathway inhibitors for advanced basal cell carcinoma patients: A systematic review and meta-analysisSuvijak Untaaveesup, Wichapol Dendumrongsup, Pornteera Srichana, et al.
Frontiers in Oncology|June 6, 2022
The Acquired Vulnerability Caused by CDK4/6 Inhibition Promotes Drug Synergism Between Oxaliplatin and Palbociclib in CholangiocarcinomaOrawan Suppramote, Sunisa Prasopporn, Satinee Aroonpruksakul, et al.
Journal of Gastroenterology and Hepatology|May 21, 2024
Global epidemiology of early-onset upper gastrointestinal cancer: trend from the Global Burden of Disease Study 2019Pojsakorn Danpanichkul, Thanida Auttapracha, Siwanart Kongarin, et al.
Frontiers in Oncology|January 23, 2023
Corrigendum: Combining the SMAC mimetic LCL161 with Gemcitabine plus Cisplatin therapy inhibits and prevents the emergence of multidrug resistance in cholangiocarcinomaSunisa Prasopporn, Orawan Suppramote, Ben Ponvilawan, et al.
JCO Precision Oncology|May 6, 2026
Immunotherapy Response and Survival Outcome by Immunophenotypic Signature in Non-Small Cell Lung CancerDhruv Bansal, Ben Ponvilawan, Dmitrii Grachev, et al.
Pageof 7